Theranostics,
Год журнала:
2024,
Номер
14(6), С. 2304 - 2328
Опубликована: Янв. 1, 2024
The
gut
microbiota
is
a
crucial
component
of
the
intricate
microecosystem
within
human
body
that
engages
in
interactions
with
host
and
influences
various
physiological
processes
pathological
conditions.In
recent
years,
association
between
dysbiosis
tumorigenesis
has
garnered
increasing
attention,
as
it
recognized
hallmark
cancer
scientific
community.However,
only
few
microorganisms
have
been
identified
potential
drivers
tumorigenesis,
enhancing
molecular
understanding
this
process
substantial
importance
clinical
relevance
for
treatment.In
review,
we
delineate
impact
on
treatment
multiple
types
while
also
analyzing
associated
mechanisms.Moreover,
discuss
utility
data
diagnosis
patient
stratification.We
further
outline
current
research
harnessing
prospects
challenges
approach.
Cell Communication and Signaling,
Год журнала:
2024,
Номер
22(1)
Опубликована: Фев. 12, 2024
Abstract
Cancer
treatment
faces
many
hurdles
and
resistance
is
one
among
them.
Anti-cancer
strategies
are
evolving
due
to
innate
acquired
capacity,
governed
by
genetic,
epigenetic,
proteomic,
metabolic,
or
microenvironmental
cues
that
ultimately
enable
selected
cancer
cells
survive
progress
under
unfavorable
conditions.
Although
the
mechanism
of
drug
being
widely
studied
generate
new
target-based
drugs
with
better
potency
than
existing
ones.
However,
broader
flexibility
in
resistance,
advanced
therapeutic
options
efficacy
need
be
explored.
Combination
therapy
an
alternative
a
success
rate
though
risk
amplified
side
effects
commonplace.
Moreover,
recent
groundbreaking
precision
immune
ways
overcome
has
revolutionized
anticancer
greater
extent
only
limitation
individual-specific
needs
further
attention.
This
review
will
focus
on
challenges
opted
withstand
current
therapies
at
molecular
level
also
highlights
emerging
-like
immunological,
stem
cell-based
may
prove
have
potential
challenge
problem
resistance.
Advanced Materials,
Год журнала:
2023,
Номер
35(22)
Опубликована: Март 25, 2023
Reactive
oxygen
species
(ROS)-mediated
tumor
catalytic
therapy
is
typically
hindered
by
gap
junction
proteins
that
form
cell-to-cell
channels
to
remove
cytotoxic
ROS,
thereby
protecting
cells
from
oxidative
damage.
In
this
work,
a
multifunctional
nanozyme,
FePGOGA,
designed
and
prepared
Fe(III)-mediated
polymerization
(FeP),
followed
glucose
oxidase
(GOx)
GAP19
peptides
co-loading
through
electrostatic
π-π
interactions.
The
FePGOGA
nanozyme
exhibits
excellent
cascade
peroxidase-
glutathione-oxidase-like
activities
efficiently
catalyze
hydrogen
peroxide
conversion
hydroxyl
radicals
convert
reduced
glutathione
oxidized
disulfide.
loaded
GOx
starves
the
tumors
aggravates
stress
decomposition,
while
block
hemichannels
inducing
degradation
of
Cx43,
thus
increasing
accumulation
intracellular
decreasing
transport
glucose.
Furthermore,
ROS
reacts
with
primary
amines
heat
shock
destroy
their
structure
function,
enabling
photothermal
at
widely
sought-after
mild
temperature
(mildPTT,
≤45
°C).
vivo
experiments
demonstrate
significant
antitumor
effectof
on
cal27
xenograft
under
near-infrared
light
irradiation.
This
study
demonstrates
successful
ablation
overcome
resistance
ROS-mediated
therapy,
providing
regulator
suppress
self-preservation
during
starvation,
mildPTT.
Signal Transduction and Targeted Therapy,
Год журнала:
2023,
Номер
8(1)
Опубликована: Сен. 8, 2023
Genome
instability
has
been
identified
as
one
of
the
enabling
hallmarks
in
cancer.
DNA
damage
response
(DDR)
network
is
responsible
for
maintenance
genome
integrity
cells.
As
cancer
cells
frequently
carry
DDR
gene
deficiencies
or
suffer
from
replicative
stress,
targeting
processes
could
induce
excessive
damages
(or
unrepaired
DNA)
that
eventually
lead
to
cell
death.
Poly
(ADP-ribose)
polymerase
(PARP)
inhibitors
have
brought
impressive
benefit
patients
with
breast
(BRCA)
mutation
homologous
recombination
deficiency
(HRD),
which
proves
concept
synthetic
lethality
treatment.
Moreover,
other
two
scenarios
inhibitor
application,
replication
stress
and
combination
chemo-
radio-
therapy,
are
under
active
clinical
exploration.
In
this
review,
we
revisited
progress
therapy
beyond
launched
first-generation
PARP
inhibitors.
Next
generation
PARP1
selective
inhibitors,
maintain
efficacy
while
mitigating
side
effects,
may
diversify
application
clinic.
Albeit
unavoidable
on-mechanism
toxicities,
several
small
molecules
checkpoints
(gatekeepers)
shown
great
promise
preliminary
results,
warrant
further
evaluations.
addition,
repair
pathways
(caretakers)
also
preclinical
development.
With
these
progresses
efforts,
envision
a
new
wave
innovations
within
come
age.
International Journal of Molecular Sciences,
Год журнала:
2023,
Номер
24(18), С. 14279 - 14279
Опубликована: Сен. 19, 2023
Aging
is
considered
the
deterioration
of
physiological
functions
along
with
an
increased
mortality
rate.
This
scientific
review
focuses
on
central
importance
genomic
instability
during
aging
process,
encompassing
a
range
cellular
and
molecular
changes
that
occur
advancing
age.
In
particular,
this
revision
addresses
genetic
epigenetic
alterations
contribute
to
instability,
such
as
telomere
shortening,
DNA
damage
accumulation,
decreased
repair
capacity.
Furthermore,
explores
aging,
including
modifications
histones,
methylation
patterns,
role
non-coding
RNAs.
Finally,
discusses
organization
chromatin
its
contribution
heterochromatin
loss,
remodeling,
in
nucleosome
histone
abundance.
conclusion,
highlights
fundamental
plays
process
underscores
need
for
continued
research
into
these
complex
biological
mechanisms.
International Journal of Molecular Sciences,
Год журнала:
2023,
Номер
24(5), С. 4741 - 4741
Опубликована: Март 1, 2023
DNA
damage
is
a
double-edged
sword
in
cancer
cells.
On
the
one
hand,
exacerbates
gene
mutation
frequency
and
risk.
Mutations
key
repair
genes,
such
as
breast
1
(BRCA1)
and/or
2
(BRCA2),
induce
genomic
instability
promote
tumorigenesis.
other
induction
of
using
chemical
reagents
or
radiation
kills
cells
effectively.
Cancer-burdening
mutations
repair-related
genes
imply
relatively
high
sensitivity
to
chemotherapy
radiotherapy
because
reduced
efficiency.
Therefore,
designing
specific
inhibitors
targeting
enzymes
pathway
an
effective
way
synthetic
lethality
with
therapeutics.
This
study
reviews
general
pathways
involved
potential
proteins
that
could
be
targeted
for
Cancer Communications,
Год журнала:
2024,
Номер
44(3), С. 297 - 360
Опубликована: Фев. 4, 2024
Abstract
Cancer
is
a
leading
cause
of
death
worldwide.
Targeted
therapies
aimed
at
key
oncogenic
driver
mutations
in
combination
with
chemotherapy
and
radiotherapy
as
well
immunotherapy
have
benefited
cancer
patients
considerably.
Tumor
protein
p53
(
TP53
),
crucial
tumor
suppressor
gene
encoding
p53,
regulates
numerous
downstream
genes
cellular
phenotypes
response
to
various
stressors.
The
affected
are
involved
diverse
processes,
including
cell
cycle
arrest,
DNA
repair,
senescence,
metabolic
homeostasis,
apoptosis,
autophagy.
However,
accumulating
recent
studies
continued
reveal
novel
unexpected
functions
governing
the
fate
tumors,
for
example,
ferroptosis,
immunity,
microenvironment
microbiome
metabolism.
Among
possibilities,
evolutionary
plasticity
most
controversial,
partially
due
dizzying
array
biological
that
been
attributed
different
regulatory
mechanisms
signaling.
Nearly
40
years
after
its
discovery,
this
remains
somewhat
enigmatic.
intricate
regulating
during
treatment
only
tip
iceberg
respect
equally
complicated
structural
biology,
which
has
painstakingly
revealed.
Additionally,
mutation
one
significant
genetic
alterations
cancer,
contributing
rapid
growth
progression.
Here,
we
summarized
advances
implicate
altered
modulating
therapies,
chemotherapy,
radiotherapy,
immunotherapy.
Furthermore,
also
discussed
potential
strategies
targeting
therapeutic
option
cancer.
Advanced Materials,
Год журнала:
2024,
Номер
36(21)
Опубликована: Фев. 14, 2024
Activation
of
the
cyclic
GMP-AMP
synthase-stimulator
interferon
genes
(cGAS-STING)
pathway
has
emerged
as
an
efficient
strategy
to
improve
therapeutic
outcomes
immunotherapy.
However,
"constantly
active"
mode
current
STING
agonist
delivery
strategies
typically
leads
off-target
toxicity
and
hyperimmunity.
To
address
this
critical
issue,
herein
a
metal-organic
frameworks-based
nanoagonist
(DZ@A7)
featuring
tumor-specific
near-infrared
(NIR)
light-enhanced
decomposition
is
constructed
for
precisely
localized
activation
photodynamic-metalloimmunotherapy.
The
engineered
enabled
generation
mitochondria-targeted
reactive
oxygen
species
under
NIR
irradiation
specifically
release
mitochondrial
DNA
(mtDNA)
inhibit
repair
nuclear
via
hypoxia-responsive
drugs.
Oxidized
tumor
mtDNA
serves
endogenous
danger-associated
molecular
pattern
that
activates
cGAS-STING
pathway.
Concurrently,
NIR-accelerated
zinc
ions
overloading
in
cancer
cells
further
enhance
cGAS
enzymatic
activity
through
metalloimmune
effects.
By
combining
synergistically
enhanced
triggered
by
irradiation,
facilitated
maturation
dendritic
infiltration
cytotoxic
T
lymphocytes
primary
eradication,
which
also
established
long-term
anti-tumor
immunity
suppress
metastasis.
Therefore,
developed
NIR-triggered,
agonist-free,
tandem-amplified
pathway,
thereby
offering
distinct
paradigm
Cancer Biology & Therapy,
Год журнала:
2024,
Номер
25(1)
Опубликована: Янв. 30, 2024
Fusobacterium
nucleatum,
an
anaerobic
Gram-negative
bacterium
primarily
residing
in
the
oral
cavity,
has
garnered
significant
attention
for
its
emerging
role
cancer
progression
and
prognosis.
While
extensive
research
revealed
mechanistic
links
between
nucleatum
colorectal
cancer,
a
comprehensive
review
spanning
presence
metastatic
implications
cancers
beyond
origin
is
conspicuously
absent.
This
paper
broadens
our
perspective
from
to
various
malignancies
associated
with
including
oral,
pancreatic,
esophageal,
breast,
gastric
cancers.
Our
central
focus
unravel
mechanisms
governing
colonization,
initiation,
promotion
of
metastasis
across
diverse
types.
Additionally,
we
explore
nucleatum's
adverse
impacts
on
therapies,
particularly
within
domains
immunotherapy
chemotherapy.
Furthermore,
this
underscores
clinical
significance
as
potential
tumor
biomarker
therapeutic
target,
offering
novel
outlook
applicability
detection
prognostic
assessment.
Analytical Chemistry,
Год журнала:
2024,
Номер
96(5), С. 2117 - 2123
Опубликована: Янв. 25, 2024
Despite
the
progress
that
has
been
made
in
diverse
DNA-based
nanodevices
to
situ
monitor
activity
of
DNA
repair
enzymes
living
cells,
significance
improving
both
sensitivity
and
specificity
remained
largely
neglected
understudied.
Herein,
we
propose
a
regulatable
nanodevice
specifically
for
early
evaluation
cancer
mediated
by
genomic
instability.
Concretely,
an
AND
logic
gate-regulated
DNAzyme
nanoflower
was
rationally
designed
self-assembly
duplex
modified
with
apurinic/apyrimidinic
(AP)
site
methyl
lesion
site.
The
could
be
reconfigured
under
AP
sites
O6-methylguanine
endonuclease
1
(APE1)
methyltransferase
(MGMT)
produce
fluorescent
signal,
realizing
sensitive
monitoring
APE1
MGMT.
Compared
free
duplex,
response
increased
60%,
due
effective
enrichment
probes
structure.
More
importantly,
have
demonstrated
dual-enzyme
activated
strategy
allows
imaging
specific
cells
gate
manner
using
MCF-7
as
cell
model,
imaging.
This
multifunctional
provides
simple
tool
simultaneously
visualizing
multiple
enzymes,
holding
great
potential
clinical
diagnosis
drug
discovery.